verapamil hydrochloride

Generic: verapamil hydrochloride

Labeler: nucare pharmaceuticals,inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name verapamil hydrochloride
Generic Name verapamil hydrochloride
Labeler nucare pharmaceuticals,inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

verapamil hydrochloride 80 mg/1

Manufacturer
NuCare Pharmaceuticals,Inc.

Identifiers & Regulatory

Product NDC 68071-3434
Product ID 68071-3434_2d58716c-2371-b0e1-e063-6294a90a408e
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA071881
Listing Expiration 2026-12-31
Marketing Start 2011-01-07

Pharmacologic Class

Classes
calcium channel antagonists [moa] calcium channel blocker [epc] cytochrome p450 3a inhibitors [moa] cytochrome p450 3a4 inhibitors [moa] p-glycoprotein inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 680713434
Hyphenated Format 68071-3434

Supplemental Identifiers

RxCUI
897683
UPC
0368071343403
UNII
V3888OEY5R

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name verapamil hydrochloride (source: ndc)
Generic Name verapamil hydrochloride (source: ndc)
Application Number ANDA071881 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 80 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (68071-3434-0)
source: ndc

Packages (1)

Ingredients (1)

verapamil hydrochloride (80 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "2d58716c-2371-b0e1-e063-6294a90a408e", "openfda": {"upc": ["0368071343403"], "unii": ["V3888OEY5R"], "rxcui": ["897683"], "spl_set_id": ["fe0583bf-9986-e01e-e053-6294a90a0b26"], "manufacturer_name": ["NuCare Pharmaceuticals,Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (68071-3434-0)", "package_ndc": "68071-3434-0", "marketing_start_date": "20230608"}], "brand_name": "VERAPAMIL HYDROCHLORIDE", "product_id": "68071-3434_2d58716c-2371-b0e1-e063-6294a90a408e", "dosage_form": "TABLET", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "68071-3434", "generic_name": "VERAPAMIL HYDROCHLORIDE", "labeler_name": "NuCare Pharmaceuticals,Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VERAPAMIL HYDROCHLORIDE", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "80 mg/1"}], "application_number": "ANDA071881", "marketing_category": "ANDA", "marketing_start_date": "20110107", "listing_expiration_date": "20261231"}